FRANCISCO
GALEANO VALLE
Profesor asociado de Ciencias de la Salud
Cardiovascular Research Foundation
Manhattan, EE. UU.Publicaciones en colaboración con investigadores/as de Cardiovascular Research Foundation (10)
2024
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711
2023
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
2022
-
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism
Chest, Vol. 161, Núm. 2, pp. 524-534
-
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
Viruses, Vol. 14, Núm. 2
2021
-
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989
-
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
European Respiratory Journal, Vol. 58, Núm. 1
2020
-
Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score
European Respiratory Journal, Vol. 56, Núm. 6
-
Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project
Clinical and Applied Thrombosis/Hemostasis, Vol. 26